関連する実験動画
Updated: Jan 23, 2026

09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
43.6K
モノクローナル抗体によるアニオポエチンのようなタンパク質3の抑制は,高血糖症におけるトリグリセリドを減少させる
Zahid Ahmad1, Poulabi Banerjee2, Sara Hamon2
1Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas (Z.A.).
Circulation
|June 28, 2019
まとめ
エヴィナキュマブは,ANGPTL3阻害剤で,2つの第1相試験において,高甘油症患者のトリグリセリドを効果的に低下させた. 薬はよく耐えるので 心血管に良い効果があると考えられます
科学分野:
- 薬理学と治療法
- 心血管医学
- 脂質代謝
背景:
- 心血管疾患の重要な危険因子であり,しばしばリポタンパク質のクリアランスの低下に関連しています.
- アンジオポエチン類似タンパク質3 (ANGPTL3) は,リポタンパク質リパースを阻害し,それによってトリグリセリド濃度を増やすことで重要な役割を果たします.
- 標的型ANGPTL3阻害剤であるエヴィナキュマブは,前回の研究でトリグリセリドを下げるのに有望であることが示されました.
研究 の 目的:
- エヴィナキュマブの安全性,耐受性,および有効性を評価する.
- トリグリセリドおよびその他の脂質レベルに対するエヴィナキュマブの用量依存的効果を評価する.
- エヴィナキュマブの効果とプラセボの効果を2つの第1相臨床試験で比較した.
主な方法:
- 2つのランダム化,プラセボ対照のフェーズ1試験 (単一の上昇用量 (SAD) と複数の上昇用量 (MAD)) が実施された.
- 参加者 (SADではn=83,MADではn=56) のトリグリセリドは150~450mg/dL,LDLコレステロールは100mg/dLでした.
- エビナキュマブは皮膚下または静脈内経由で様々な用量と頻度で投与され,副作用と脂質プロフィールをモニタリングした.
主要な成果:
- エビナキュマブは一般的によく耐えており,深刻な有害事象や中止は報告されていません.
- 投与量によるトリグリセリドの減少が観察され,最大減少率は76. 9% (SAD) と83. 1% (MAD) であった.
- 肝臓酵素とクレアチニン・フォスフォキナーゼの過渡的な上昇は認められたが,投与量に関係ないし,深刻ではなかった.
結論:
- エビナキュマブは,高トリグリセリデミアの患者で好ましい安全性プロファイルと有意なトリグリセリド低下効果を示した.
- 観察された脂質の変化は,心血管リスクの低下に関連したANGPTL3機能喪失変異に見られるものと一致しています.
- エヴィナキュマブによるANGPTL3抑制は,高トリグリセリデミアの管理と,潜在的に心血管疾患の改善のための有望な治療戦略です.
関連する概念動画
Feedback Inhibition
56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Antibody Structure
65.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K
Reducing Line Loss
370
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
370
Enzyme Inhibition
91.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Methods of reducing fever
1.2K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
1.2K
Inhibition of Cdk Activity
5.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K

